Kukje Pharma Co., Ltd. (KRX:002720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,650.00
-15.00 (-0.32%)
Last updated: Mar 25, 2025

Kukje Pharma Revenue

In the year 2024, Kukje Pharma had annual revenue of 156.46B KRW with 15.58% growth. Kukje Pharma had revenue of 41.64B in the quarter ending December 31, 2024, with 17.96% growth.

Revenue
156.46B
Revenue Growth
+15.58%
P/S Ratio
0.59
Revenue / Employee
641.24M
Employees
244
Market Cap
92.04B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024156.46B21.09B15.58%
Dec 31, 2023135.37B8.79B6.94%
Dec 31, 2022126.58B6.84B5.71%
Dec 31, 2021119.75B-10.65B-8.17%
Dec 31, 2020130.39B19.27B17.34%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition